Clinical Trials Browser

Phase 2 × dinaciclib × 90 days × Clear all

NCT00937937 2026-03-18

Dinaciclib in Treating Patients With Stage IV Melanoma

Phase 2 Active not recruiting

72 enrolled 14 charts

Melanoma